Government and Regulations

FDA announces new potential side effects for varenicline


 

References

The Food and Drug Administration is warning physicians and patients that taking varenicline for smoking cessation can change a patient’s reaction to alcohol and can cause seizures* in patients without prior history.

Some patients who have drunk alcohol while taking varenicline, marketed as Chantix, have reported decreased tolerance to alcohol, including symptoms such as increased drunkenness, unusual or aggressive behavior, or memory loss. Patients have also reported incidence of seizure within a month of starting varenicline, despite having no previous history of seizure.

“Until patients know how Chantix affects their ability to tolerate alcohol, they should decrease the amount of alcohol they drink. Patients who have a seizure while taking Chantix should stop the medicine and seek medical attention immediately,” the FDA recommended.

Find the full announcement on the FDA website.

*Correction, 3/11/2015: An earlier version of this article misstated one of the side effects of varenicline.

Recommended Reading

Sexsomnia may gain more awareness after DSM-5 inclusion
MDedge Psychiatry
Cigarette smoking rates among U.S. adults hit all-time low
MDedge Psychiatry
Anxiety disorders drive, worsen migraine symptoms
MDedge Psychiatry
Hookah, snus users more likely to start smoking
MDedge Psychiatry
Study ignites concern that e-cigarettes may ‘renormalize’ smoking
MDedge Psychiatry
Cheaper cytisine topped nicotine replacement therapy for smoking cessation
MDedge Psychiatry
Insomnia and e-books
MDedge Psychiatry
Teen screen and electronic use linked to less sleep
MDedge Psychiatry
VIDEO: Varenicline may help smokers quit gradually
MDedge Psychiatry
Varenicline facilitates gradual smoking cessation
MDedge Psychiatry